M
Michele Ghidini
Researcher at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Publications - 183
Citations - 4329
Michele Ghidini is an academic researcher from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 26, co-authored 133 publications receiving 2446 citations. Previous affiliations of Michele Ghidini include Vita-Salute San Raffaele University & Institute of Cancer Research.
Papers
More filters
Journal ArticleDOI
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis
Fausto Petrelli,Gianluca Tomasello,Karen Borgonovo,Michele Ghidini,Luca Turati,Pierpaolo Dallera,Rodolfo Passalacqua,Giovanni Sgroi,Sandro Barni +8 more
TL;DR: CC side should be acknowledged as a criterion for establishing prognosis in all stages of disease, and should represent a stratification factor for future adjuvant studies.
Journal ArticleDOI
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kohei Shitara,Toshihiko Doi,M Dvorkin,Wasat Mansoor,Hendrik-Tobias Arkenau,Aliaksandr Prokharau,Maria Alsina,Michele Ghidini,C. Faustino,Vera Gorbunova,Edvard Zhavrid,Kazuhiro Nishikawa,Ayumu Hosokawa,Suayib Yalcin,Kazumasa Fujitani,Giordano D. Beretta,Eric Van Cutsem,Robert Winkler,Lukas Makris,David H. Ilson,Josep Tabernero +20 more
TL;DR: Trifluridine/tipiracil significantly improved overall survival compared with placebo and was well tolerated in this heavily pretreated population of patients with advanced gastric cancer and could be a new treatment option in this population who represent a high unmet medical need.
Journal ArticleDOI
Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.
Fausto Petrelli,Francesca Trevisan,Mary Cabiddu,Giovanni Sgroi,Lorenza Bruschieri,Emanuele Rausa,Michele Ghidini,Luca Turati +7 more
TL;DR: The addition of induction or consolidation chemotherapy to standard neoadjuvant chemoradiotherapy results in a higher pCR rate, and large confirmatory trials should be carried out before a strong recommendation is made in favor of TNT.
Journal ArticleDOI
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial
Elizabeth C Smyth,Matteo Fassan,David Cunningham,William H. Allum,Alicia Okines,Andrea Lampis,Jens C. Hahne,Massimo Rugge,Clare Peckitt,Matthew Nankivell,Ruth Langley,Michele Ghidini,Chiara Braconi,Andrew Wotherspoon,Heike I. Grabsch,Nicola Valeri +15 more
TL;DR: In this article, the authors evaluated whether pathologic response and lymph node status after neoadjuvant chemotherapy are prognostic in patients treated in the MAGIC trial, and compared the results using the Kaplan-Meier method and the log-rank test.
Journal ArticleDOI
Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Fausto Petrelli,Diego Signorelli,Michele Ghidini,Antonio Ghidini,Elio Gregory Pizzutilo,Lorenzo Ruggieri,Mary Cabiddu,Karen Borgonovo,Giuseppina Dognini,Matteo Brighenti,Alessandro De Toma,Erika Rijavec,Marina Chiara Garassino,Francesco Grossi,Gianluca Tomasello +14 more
TL;DR: A systematic review and meta-analysis of published studies to evaluate the correlation between steroids use, overall survival (OS), and progression-free survival (PFS) in cancer patients treated with ICIs was performed in this paper.